Tue, November 29, 2022
Mon, November 28, 2022
Fri, November 25, 2022
Thu, November 24, 2022
Wed, November 23, 2022

Mohit Bansal Initiated (XENE) at Buy and Held Target at $50 on, Nov 28th, 2022

Mohit Bansal of Wells Fargo, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $50 on, Nov 28th, 2022.

Mohit has made no other calls on XENE in the last 4 months.



There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Mohit's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Mohit


  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $49 on, Friday, November 11th, 2022
  • Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $52 on, Wednesday, October 19th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $49 on, Tuesday, October 11th, 2022
  • Jason Gerberry of "B of A Securities" Initiated at Strong Buy on, Monday, August 29th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $46 on, Thursday, August 11th, 2022